• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

葡萄糖脑苷脂酶在帕金森病发病机制中的作用。

The role of glucocerebrosidase in Parkinson disease pathogenesis.

机构信息

Department of Clinical Neuroscience, Institute of Neurology, University College London, UK.

出版信息

FEBS J. 2018 Oct;285(19):3591-3603. doi: 10.1111/febs.14393. Epub 2018 Feb 19.

DOI:10.1111/febs.14393
PMID:29385658
Abstract

GBA encodes the lysosomal enzyme glucocerebrosidase (GCase), an enzyme involved in sphingolipid metabolism. Mutations in the GBA gene are numerically the most important risk factor for developing Parkinson disease (PD) accounting for at least 5% of all PD cases. Furthermore, loss of GCase activity is found in sporadic PD brains. Lysosomal dysfunction is thought to play a principal role in PD pathogenesis and in particular its effect on the metabolism of α-synuclein. A hallmark of PD is the presence of intraneuronal protein inclusions called Lewy bodies, which are composed mainly of α-synuclein. Cellular and animal models of GCase deficiency result in lysosomal dysfunction, and in particular the autophagy lysosome pathway, resulting in the accumulation of α-synuclein. Some forms of mutant GCase unfold in the endoplasmic reticulum activating the unfolded protein response, which might also contribute to PD pathogenesis. It has also been suggested that accumulation of GCase substrates glucosylceramide/glucosylsphingosine may contribute to GBA-PD pathogenesis. Mitochondrial dysfunction and neuroinflammation are associated with GCase deficiency and have also been implicated in the aetiology of PD. This review discusses these points and highlights potential treatments that might be effective in treating GCase deficiency in PD.

摘要

GBA 编码溶酶体酶葡萄糖脑苷脂酶(GCase),一种参与鞘脂代谢的酶。GBA 基因的突变是导致帕金森病(PD)的最重要危险因素之一,至少占所有 PD 病例的 5%。此外,在散发性 PD 脑中发现 GCase 活性丧失。溶酶体功能障碍被认为在 PD 的发病机制中起主要作用,特别是对α-突触核蛋白代谢的影响。PD 的一个标志是存在称为路易体的神经元内蛋白包涵体,其主要由α-突触核蛋白组成。GCase 缺乏的细胞和动物模型导致溶酶体功能障碍,特别是自噬溶酶体途径,导致α-突触核蛋白的积累。一些形式的突变 GCase 在内质网中展开,激活未折叠蛋白反应,这也可能导致 PD 的发病机制。也有人认为,GCase 底物葡萄糖脑苷脂/葡萄糖鞘氨醇的积累可能有助于 GBA-PD 的发病机制。线粒体功能障碍和神经炎症与 GCase 缺乏有关,也与 PD 的病因有关。这篇综述讨论了这些观点,并强调了可能对治疗 PD 中的 GCase 缺乏有效的潜在治疗方法。

相似文献

1
The role of glucocerebrosidase in Parkinson disease pathogenesis.葡萄糖脑苷脂酶在帕金森病发病机制中的作用。
FEBS J. 2018 Oct;285(19):3591-3603. doi: 10.1111/febs.14393. Epub 2018 Feb 19.
2
Variants and Parkinson Disease: Mechanisms and Treatments.变异与帕金森病:机制与治疗。
Cells. 2022 Apr 8;11(8):1261. doi: 10.3390/cells11081261.
3
Glucocerebrosidase deficiency in substantia nigra of parkinson disease brains.帕金森病脑黑质中葡萄糖脑苷脂酶缺乏。
Ann Neurol. 2012 Sep;72(3):455-63. doi: 10.1002/ana.23614.
4
Glucocerebrosidase and Parkinson disease: Recent advances.葡萄糖脑苷脂酶与帕金森病:最新进展
Mol Cell Neurosci. 2015 May;66(Pt A):37-42. doi: 10.1016/j.mcn.2015.03.013. Epub 2015 Mar 20.
5
The relationship between glucocerebrosidase mutations and Parkinson disease.葡萄糖脑苷脂酶突变与帕金森病之间的关系。
J Neurochem. 2016 Oct;139 Suppl 1(Suppl Suppl 1):77-90. doi: 10.1111/jnc.13385. Epub 2016 Feb 10.
6
Glucocerebrosidase-associated Parkinson disease: Pathogenic mechanisms and potential drug treatments.葡萄糖脑苷脂酶相关帕金森病:发病机制与潜在药物治疗。
Neurobiol Dis. 2022 May;166:105663. doi: 10.1016/j.nbd.2022.105663. Epub 2022 Feb 17.
7
Autophagic lysosome reformation dysfunction in glucocerebrosidase deficient cells: relevance to Parkinson disease.葡糖脑苷脂酶缺乏细胞中的自噬性溶酶体再形成功能障碍:与帕金森病的相关性
Hum Mol Genet. 2016 Aug 15;25(16):3432-3445. doi: 10.1093/hmg/ddw185. Epub 2016 Jul 4.
8
Glucocerebrosidase deficiency promotes release of α-synuclein fibrils from cultured neurons.葡萄糖脑苷脂酶缺乏促进培养神经元中α-突触核蛋白原纤维的释放。
Hum Mol Genet. 2020 Jun 27;29(10):1716-1728. doi: 10.1093/hmg/ddaa085.
9
Lysosomal functions and dysfunctions: Molecular and cellular mechanisms underlying Gaucher disease and its association with Parkinson disease.溶酶体的功能与功能障碍:戈谢病及其与帕金森病关联的分子和细胞机制
Adv Drug Deliv Rev. 2022 Aug;187:114402. doi: 10.1016/j.addr.2022.114402. Epub 2022 Jun 25.
10
Targeting the GBA1 pathway to slow Parkinson disease: Insights into clinical aspects, pathogenic mechanisms and new therapeutic avenues.靶向 GBA1 通路以减缓帕金森病:临床方面、发病机制和新治疗途径的见解。
Pharmacol Ther. 2023 Jun;246:108419. doi: 10.1016/j.pharmthera.2023.108419. Epub 2023 Apr 19.

引用本文的文献

1
A novel allosteric GCase modulator prevents Tau accumulation in GBA1 and GBA1 cellular models.一种新型变构葡糖脑苷脂酶调节剂可防止GBA1及GBA1细胞模型中tau蛋白积聚。
Sci Rep. 2025 May 21;15(1):17646. doi: 10.1038/s41598-025-02346-8.
2
Brain age in genetic and idiopathic Parkinson's disease.遗传性和特发性帕金森病中的脑龄
Brain Commun. 2024 Dec 20;6(6):fcae382. doi: 10.1093/braincomms/fcae382. eCollection 2024.
3
Glucocerebrosidase deficiency leads to neuropathology via cellular immune activation.葡萄糖脑苷脂酶缺乏通过细胞免疫激活导致神经病理学。
PLoS Genet. 2024 Nov 11;20(11):e1011105. doi: 10.1371/journal.pgen.1011105. eCollection 2024 Nov.
4
A Novel Rare PSEN2 Val226Ala in PSEN2 in a Korean Patient with Atypical Alzheimer's Disease, and the Importance of PSEN2 5th Transmembrane Domain (TM5) in AD Pathogenesis.一种新型罕见 PSEN2 Val226Ala 突变导致的韩国非典型阿尔茨海默病病例,以及 PSEN2 第 5 跨膜结构域(TM5)在 AD 发病机制中的重要性。
Int J Mol Sci. 2024 Sep 6;25(17):9678. doi: 10.3390/ijms25179678.
5
A review on Gaucher disease: therapeutic potential of β-glucocerebrosidase-targeted mRNA/saRNA approach.戈谢病综述:靶向β-葡萄糖脑苷脂酶的mRNA/saRNA疗法的治疗潜力
Int J Biol Sci. 2024 Mar 17;20(6):2111-2129. doi: 10.7150/ijbs.87741. eCollection 2024.
6
Glucocerebrosidase deficiency leads to neuropathology via cellular immune activation.葡萄糖脑苷脂酶缺乏通过细胞免疫激活导致神经病理学改变。
bioRxiv. 2023 Dec 13:2023.12.13.571406. doi: 10.1101/2023.12.13.571406.
7
Pharmacogenomics of Dementia: Personalizing the Treatment of Cognitive and Neuropsychiatric Symptoms.痴呆症的药物基因组学:个性化认知和神经精神症状的治疗。
Genes (Basel). 2023 Nov 6;14(11):2048. doi: 10.3390/genes14112048.
8
Targeting the Cysteine Redox Proteome in Parkinson's Disease: The Role of Glutathione Precursors and Beyond.靶向帕金森病中的半胱氨酸氧化还原蛋白质组:谷胱甘肽前体及其他的作用
Antioxidants (Basel). 2023 Jun 30;12(7):1373. doi: 10.3390/antiox12071373.
9
Multi-omic approach characterises the neuroprotective role of retromer in regulating lysosomal health.多组学方法描绘了 retromer 在调节溶酶体健康方面的神经保护作用。
Nat Commun. 2023 May 29;14(1):3086. doi: 10.1038/s41467-023-38719-8.
10
Recent Advances in the Treatment of Genetic Forms of Parkinson's Disease: Hype or Hope?近年来治疗帕金森病遗传形式的新进展:炒作还是希望?
Cells. 2023 Feb 27;12(5):764. doi: 10.3390/cells12050764.